About JFNCX
Janus Henderson Global Life Sciences Fund Class C is an open-end mutual fund focused on achieving long-term capital growth by investing in companies engaged in the life sciences sector. Its portfolio spans a diverse range of industries within healthcare, including pharmaceuticals, biotechnology, medical devices, and healthcare equipment and services. The fund typically allocates at least 80% of its net assets to equities of firms with a life sciences orientation and maintains a balanced approach across subsectors, targeting companies of various sizes and geographies, including developed and, to a lesser extent, emerging markets.
Notably, the fund is actively managed, employing a fundamental, bottom-up stock selection process to identify growth opportunities among companies that address unmet medical needs or aim to improve the efficiency of healthcare systems. The portfolio often has significant exposure to large, globally recognized healthcare firms, with the top ten holdings accounting for a substantial portion of assets.
Janus Henderson Global Life Sciences Fund Class C serves as a specialized vehicle for investors seeking exposure to the innovation-driven healthcare space, benchmarked primarily against the MSCI World Health Care Index. The fund is managed by an experienced team with a deep understanding of the scientific and business dimensions of the healthcare industry.
Fund Family Janus Henderson
Category Health
Performance Rating High
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol JFNCX
Share Class Class C
Index MSCI World/Health Care NR
JFNCX had a total return of 21.76% in the past year, including dividends. Since the fund's
inception, the average annual return has been 13.99%.
